APRE NASDAQ
Aprea Therapeutics, Inc.
1W: -8.7%
1M: -15.2%
3M: -7.3%
YTD: -18.5%
1Y: -52.4%
3Y: -82.7%
5Y: -99.2%
$0.69
-0.03 (-3.94%)
Weekly Expected Move ±6.9%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-05-17
Earliest Filing
2025-12-09
Latest Filing
partner: 4
target: 1
Counterparties (Filed by APRE)
5 relationshipsCompanies named in APRE's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Maxim Group LLC | MMS | partner | Placement agent for the private placement of securities | 2025-12-09 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for at-the-market offering of common stock | 2024-11-08 | View |
| Maxim Group LLC | MMS | partner | Placement agency for the private placement securities purchase agreement | 2024-03-12 | View |
| H.C. Wainwright & Co., LLC | — | partner | Counterparty to the terminated at-the-market offering agreement | 2024-03-12 | View |
| Atrin Pharmaceuticals Inc. | — | target | Target company acquired by Aprea Therapeutics, Inc. in a merger agreement. | 2022-05-17 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-28 | Other Events; Exhibits | View | |
| 2026-08-12 | Earnings Release; Other Events; Exhibits | View | |
| 2026-07-23 | Delisting Notice | View | |
| 2026-06-17 | Shareholder Vote | View | |
| 2026-05-13 | Earnings Release; Other Events; Exhibits | View | |
| 2026-04-01 | Regulation FD; Exhibits | View | |
| 2026-03-30 | Material Agreement; Unregistered Equity Sales; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-03-16 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-18 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-29 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2026-01-23 | Notice of Delisting or Transfer | View | |
| 2026-01-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-09 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-11-12 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-24 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-15 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-09 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR